Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jort Vellinga

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
International Journal of Cancer|March 7, 2017
Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and diseaseSelina Khan, Koen Oosterhuis, Kerstin Wunderlich, et al.
Human Gene Therapy|August 18, 2017
Adenoviral Type 35 and 26 Vectors with a Bidirectional Expression Cassette in the E1 Region Show an Improved Genetic Stability Profile and Potent Transgene-Specific Immune ResponseMarija Vujadinovic, Kerstin Wunderlich, Benoit Callendret, et al.
Journal of Virology|February 18, 2011
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challengeThomas W Geisbert, Michael Bailey, Lisa Hensley, et al.
Plos One|February 21, 2018
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primatesBenoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Plos One|April 25, 2018
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primatesBenoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
NPJ Vaccines|October 21, 2020
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responsesRinke Bos, Lucy Rutten, Joan E M van der Lubbe, et al.
NPJ Vaccines|March 17, 2023
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2Maarten Swart, Joan van der Lubbe, Sonja Schmit-Tillemans, et al.
Nature|January 20, 2021
Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaquesNoe B Mercado, Roland Zahn, Frank Wegmann, et al.
Nature|July 31, 2020
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaquesNoe B Mercado, Roland Zahn, Frank Wegmann, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
International Journal of Cancer|March 7, 2017
Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and diseaseSelina Khan, Koen Oosterhuis, Kerstin Wunderlich, et al.
Human Gene Therapy|August 18, 2017
Adenoviral Type 35 and 26 Vectors with a Bidirectional Expression Cassette in the E1 Region Show an Improved Genetic Stability Profile and Potent Transgene-Specific Immune ResponseMarija Vujadinovic, Kerstin Wunderlich, Benoit Callendret, et al.
Journal of Virology|February 18, 2011
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challengeThomas W Geisbert, Michael Bailey, Lisa Hensley, et al.
Plos One|February 21, 2018
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primatesBenoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Plos One|April 25, 2018
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primatesBenoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
NPJ Vaccines|October 21, 2020
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responsesRinke Bos, Lucy Rutten, Joan E M van der Lubbe, et al.
NPJ Vaccines|March 17, 2023
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2Maarten Swart, Joan van der Lubbe, Sonja Schmit-Tillemans, et al.
Nature|January 20, 2021
Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaquesNoe B Mercado, Roland Zahn, Frank Wegmann, et al.
Nature|July 31, 2020
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaquesNoe B Mercado, Roland Zahn, Frank Wegmann, et al.
Pageof 3